Protalix BioTherapeutics, Inc. (PLX) Deferred Tax Assets, Valuation Allowance USD 2011 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Protalix BioTherapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2011 to 2023.
  • Protalix BioTherapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $51.6 M, a 11.8% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $51.6 M -$6.93 M -11.8% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $58.6 M -$2.97 M -4.83% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $61.5 M -$2.24 M -3.51% Dec 31, 2021 10-K 2024-03-14
Q4 2020 $63.8 M +$4.25 M +7.15% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $59.5 M +$3.9 M +7% Dec 31, 2019 10-K 2021-03-30
Q4 2018 $55.6 M -$2.76 M -4.72% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $58.4 M +$16.3 M +38.9% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $42 M +$5 M +13.5% Dec 31, 2016 10-K 2018-03-06
Q4 2015 $37 M -$3.07 M -7.66% Dec 31, 2015 10-K 2017-03-16
Q4 2014 $40.1 M +$1.69 M +4.39% Dec 31, 2014 10-K 2016-03-08
Q4 2013 $38.4 M +$6.89 M +21.8% Dec 31, 2013 10-K 2015-03-12
Q4 2012 $31.5 M +$17.8 M +129% Dec 31, 2012 10-K 2014-03-13
Q4 2011 $13.8 M Dec 31, 2011 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.